AiCure, an AI and advanced data analytics company focused on improving clinical trials, today announced new senior leadership members to help steer the company’s future success, including a new Chief Financial Officer, Chief Marketing Officer, Senior Director of Digital Biomarker Development, and two Directors of Strategic Partnerships. AiCure’s bolstered leadership, in addition to receiving two industry accolades and achieving a significant platform milestone, further establishes the company as a leader in improving patient care and drug development.
New leadership to foster momentum and strategic partnerships
AiCure has added the following new senior team members to contribute to the company’s growth:
- Brian Jung, MBA, MPH, Chief Financial Officer: Mr. Jung has extensive experience building corporate infrastructure and raising funds for AI-enabled health technology companies. He previously served as CFO at Arterys, Karius, and Nanomix. As Chief Business Development Officer at Alameda Hospital, Mr. Jung helped to create the Alameda Health System, and as CFO at Cal eConnect, he helped equip the State of California with health information exchange (HIE).
- Lynne Rowland, Chief Marketing Officer: Ms. Rowland has been in healthcare since 2006. Before joining AiCure, she served as Chief Marketing Officer for GE Healthcare’s Clinical Systems Services division, and as a partner at Suazio Consulting for seven years where her role included marketing consulting, brand strategy, new product commercialization, and other projects across global Life Sciences and Healthcare clients. She also led marketing for other organizations including for The Advisory Board Company through its sale to Optum.
- Aaron Masino, PhD, Senior Director of Digital Biomarker Development: In this role, Dr. Masino provides scientific leadership for novel digital biomarker development and clinical data science research. Previously, he was an Assistant Professor in the Department of Anesthesiology and Critical Care in the Perelman School of Medicine at the University of Pennsylvania and The Children’s Hospital of Philadelphia, where he researched the application and development of machine learning methods to challenges in pediatric medicine.
Also Read: Global Cloud Services Spending to Exceed $1 Trillion by 2024
- Nina Taylor, MA, Director, Strategic Partnerships: Ms. Taylor has more than 14 years of experience in instructional design, adult learning theories, continuing medical education, social impact, fundraising and partnership development. Prior to joining AiCure, Ms. Taylor served as Vice President of Learning and Education for the American Society for Radiation Oncology, and as the Deputy Director for the Division of Education for the American Psychiatric Association.
- Viren Kavia, Director, Strategic Partnerships: In this role, Mr. Kavia is focused on strengthening AiCure’s partner ecosystem, including working with global and regional CROs, sponsors, and technology services companies. Prior to joining AiCure, Mr. Kavia held numerous senior client-facing roles with industry leading technology and services companies, including Medidata, Symphony Health (PRA), IMS Health (IQVIA) and Siebel Systems.
“At AiCure, we share a common vision – to drive more efficient and intelligent decision-making in life sciences and healthcare to improve the lives and care of people worldwide,” said Dr. Ed Ikeguchi, CEO of AiCure. “I’m thrilled to have these industry experts join us in this commitment as we make this vision a reality.”
